6 results
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
HF outcomes in HFrEF ... on GDMT, with or ... HF outcomes in HFrEF ... on GDMT, with or ... visualabstract #table
Oral Antihypertensive Medications - Selection by Comorbidities
Comorbidities: 
 • Stable Angina, HFpEF, HFrEF, AFib, TAA/Marfan, Aortic
Angina, HFpEF, ... HFrEF, AFib, TAA ... Dissection • CKD ... #pharmacology #table ... #management
Guideline-Directed Medical Therapy (GDMT) in HFrEF and CKD

 • Class I pillars of HFrEF GDMT across
) in HFrEF and CKD ... Class I pillars of HFrEF ... therapies" for HFrEF ... used in HFrEF: ... #CKD #HFrEF #management
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
angiotensin-receptor blocker; CAD ... ejection fraction; GDMT ... heart failure; HFpEF ... ejection fraction; HFrEF ... ACCAHA #Algorithm #Management
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Heart Failure - Diagnosis ... Guidelines: • ACC ... patients with HFrEF ... deficiency #CHF #HFrEF ... #management #algorithm
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
release Diagnosis ... mortality and CV ... deficiency #CHF #HFrEF ... #heartfailure #diagnosis ... #management #cardiology